Literature DB >> 14732946

[Hypertension, diabetes mellitus and comorbidity in primary care].

H U Wittchen1, P Krause, M Höfler, H Pfister, E Ritz, B Göke, H Lehnert, D Tschöpe, W Kirch, D Pittrow, A M Sharma, P Bramlage, B Küpper, T Unger.   

Abstract

Almost every second patient seeing a primary care doctor suffers from arterial hypertension and about every fifth has diabetes mellitus. These diseases often occur at the same time. They are associated in more than 80% of the cases with other severe concomitant and subsequent diseases (heart attack, stroke, renal failure, neuropathy etc.). The magnitude especially of subsequent and concomitant diseases, the dimension of the personal suffering and the immense diagnostic and therapeutic challenges for the doctors have been massively underestimated so far. The article informs about the prevalence of the above disease, and structure of the problem. Before the background of an extremely high patient load seen by German General Physicians, the mainstay challenge is highlighted how to achieve further improvements of the quality of care on the basis of scientific guidelines alone, without a concomitant change in the system structure.

Entities:  

Mesh:

Year:  2003        PMID: 14732946

Source DB:  PubMed          Journal:  Fortschr Med Orig


  3 in total

1.  Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline.

Authors:  Peter Bramlage; Christiane Binz; Anselm K Gitt; Michael Krekler; Tanja Plate; Evelin Deeg; Diethelm Tschöpe
Journal:  Cardiovasc Diabetol       Date:  2010-09-16       Impact factor: 9.951

Review 2.  [Headache in the elderly].

Authors:  V M Reinisch; C J Schankin; J Felbinger; P Sostak; A Straube
Journal:  Schmerz       Date:  2008-02       Impact factor: 1.107

3.  Prevalence of diabetes and hypertension and their interaction effects on cardio-cerebrovascular diseases: a cross-sectional study.

Authors:  Zhehui Wang; Tubao Yang; Hanlin Fu
Journal:  BMC Public Health       Date:  2021-06-25       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.